NCNA · NuCana plc
Market Cap
$5.95M
Shares
4.16M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.43
Open$1.38
Day$1.36–1.44
52W close$1.21–7.02
Avg vol 30d72K
Short int134K · 3.2% float · 3.0d
Short vol55%
DataAug 2025–Sep 2026
Raw chart and full-history price indicators begin at the captured split on Aug 11, 2025; bars on opposite sides are not compared.
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-53.4%
Trailing year
Short interest
3.2%
Latest settlement · 3.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.47
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−37%
below
Price vs 50-day avg
+1%
above
RSI (14)
48
neutral
MACD trend
Negative
52-week position
4%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+5%
trailing
6-month return
−25%
trailing
YTD return
−60%
this year
Relative strength
−42%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
+38% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
3.23% of float · ▼ -8.1% MoM · 3.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
11 holders — mid 3-yr range
Squeeze score
56
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
95%
annualized · 1-yr
Max drawdown
−83%
past year
ATR
9.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−37%
Bearish
Price vs 50-day avg
+1%
Bullish
RSI (14)
48
Neutral
MACD trend
Negative
Bearish
52-week position
4%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
+38% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
3.23% of float · ▼ -8.1% MoM · 3.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
11 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1
Now $1 · 4%
Range high $7
vs 200-day avg -37%
vs 50-day avg +1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NCNA
this stock
NuCana plc
|
$5.95M | -60.3% | — | — | 3.2% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$140.51B | +23.1% | +46.2% | 32.3 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$86.84B | +9.3% | +20.8% | 20.9 | 2.3% |
|
ARGX
Argenx SE
|
$65.63B | +25.3% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$59.96B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Earnings & Events
Performance
Raw-price comparisons begin at the captured split on Aug 11, 2025; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NCNA | -2.7% | +5.2% | -25.1% | -2.7% | -60.3% |
| SPY | +0.3% | +0.6% | +16.7% | +0.8% | +13.4% |
| vs SPY | -3.0% | +4.6% | -41.9% | -3.5% | -73.7% |